Vuja De Sciences
Vuja De is dedicated to developing cancer metastasis treatments that prevent cancer progression and recurrence.
7 employees · est. 2017
Nerviano Medical Sciences - Part of NMS Group is the older company (2004 vs 2017); Nerviano Medical Sciences - Part of NMS Group is the larger of the two.
Side-by-Side Comparison
| Metric | Nerviano Medical Sciences - Part of NMS Group | Vuja De Sciences |
|---|---|---|
| Founded | ||
| Founded | 2004 older | 2017 |
| Headquarters | ||
| Headquarters | Not tracked yet | Not tracked yet |
| Employees | ||
| Employees | 100 larger | 7 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Private Equity | Series Unknown |
| Total Funding | ||
| Total Funding | $1.40B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncology, Drug Discovery, Early Development, Therapeutic Approaches, Novel Mechanisms Of Action, Personalized Care, Cancer Patients, Clinical Development, Manufacturing Services, Biotech, Pharma, Oncology Drugs, International Markets, R&D | Cancer Metastasis Treatments, Preventing Cancer Progression, Recurrence Prevention, Osteosarcoma Treatment, Comparative Oncology, Metastatic Preclinical Endpoints, Drug Repurposing, Novel Preclinical Drugs, Canine Clinical Trials, Maintenance Therapy, Adjuvant Therapy, Phenotypic Screening, Pediatric Cancer, Drug Screening |
| Website | ||
| Website | nervianoms.com | vujade-life.com |
About Nerviano Medical Sciences - Part of NMS Group
Nerviano Medical Sciences is a part of NMS Group and is committed to advancing oncology drug discovery and early development. The business model revolves around collaborating on drugs at late preclinical or early clinical stages for full development and commercialization. The company was founded in...
About Vuja De Sciences
Vuja De Sciences is a biotechnology startup that is focused on developing treatments for cancer metastasis, with the aim of preventing cancer progression and recurrence. The company's initial focus is on osteosarcoma, a rare bone cancer that predominantly affects adolescents, before expanding to oth...
We will tell you when either one moves
BounceWatch watches Nerviano Medical Sciences - Part of NMS Group and Vuja De Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nerviano Medical Scien... and Vuja De Sciences — by email.
Frequently Asked Questions
Compare Nerviano Medical Sciences - Part of NMS Group with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nerviano Medical Sciences - Part of NMS Group on 12 Sep 2024, and Vuja De Sciences on 3 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.